Definitions
from The American Heritage® Dictionary of the English Language, 5th Edition.
- adjective Preventing or interfering with mitosis.
- noun An antimitotic drug.
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- adjective preventing or disrupting
mitosis - noun an agent that prevents or disrupts mitosis
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word antimitotic.
Examples
-
There are currently more than 10 investigational compounds in development across a broad scientific platform, including cytotoxic, antimitotic, anti-angiogenic agents, antivascular agents as well as supportive care therapies.
-
There are currently more than 10 compounds in development across a broad scientific platform, including cytotoxic, antimitotic, anti-angiogenic agents, antivascular agents, monoclonal antibodies and cancer vaccines, as well as supportive care therapies.
-
The Company's other therapeutic candidates include MKC-1, an oral cell-cycle regulator with activity against the mTOR pathway currently in multiple Phase 2 clinical trials for cancer, and ENMD-1198, a novel antimitotic agent currently in Phase 1 studies in advanced cancers.
-
The Company's other therapeutic candidates include MKC-1, an oral cell-cycle regulator with activity against the mTOR pathway currently in multiple Phase 2 clinical trials for cancer, and ENMD-1198, a novel antimitotic agent currently in Phase 1 studies in advanced cancers.
-
The Company's other therapeutic candidates include MKC-1, an oral cell-cycle regulator with activity against the mTOR pathway currently in multiple Phase 2 clinical trials for cancer, and ENMD-1198, a novel antimitotic agent currently in Phase 1 studies in advanced cancers.
unknown title 2009
-
An overexpression of Myc protein is able to increase endoreduplication favoring the survival of cells exposed to antimitotic poisoning.
-
An overexpression of Myc protein is able to increase endoreduplication favoring the survival of cells exposed to antimitotic poisoning.
PLoS ONE Alerts: New Articles Giuliana Gatti et al. 2009
-
The Company's other therapeutic candidates include MKC-1, an oral cell-cycle regulator with activity against the mTOR pathway currently in multiple Phase 2 clinical trials for cancer, and ENMD-1198, a novel antimitotic agent currently in Phase 1 studies in advanced cancers.
unknown title 2009
-
Action antimitotic agents progress larvae Aedes aegypti
xml's Blinklist.com 2008
-
ENMD-2076, a selective angiogenic kinase inhibitor, and ENMD-1198, a novel antimitotic agent are in Phase 1 studies in advanced cancers.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.